Try a new search

Format these results:

Searched for:

person:bottij01

Total Results:

13


The association of thrombocytopaenia and Lyme disease [Case Report]

Ballard HS; Bottino G; Bottino J
The association of asymptomatic thrombocytopaenia in six patients with acute Lyme disease is described. Recovery from thrombocytopaenia occurred shortly following antibiotic therapy. Patients residing in endemic areas for Lyme disease who present with flu-like symptoms and laboratory findings of thrombocytopaenia should prompt suspicion of acute Lyme disease. Appropriate clinical studies should be undertaken to confirm the diagnosis.
PMCID:2397887
PMID: 8183774
ISSN: 0032-5473
CID: 21007

Ondansetron and chest pain [Letter]

Ballard HS; Bottino G; Bottino J
PMID: 1357506
ISSN: 0140-6736
CID: 21010

Immunoglobulin therapy in a patient with chronic lymphocytic leukemia and recurrent infections [Case Report]

Bottino GG; Bottino JC; Greene R; Ballard HS
PMID: 3148874
ISSN: 0028-7628
CID: 21014

Liver cancer

Bottino, Joseph C.; Opfell, Richard W.; Muggia, Franco M
Boston : Nijhoff, 1985
Extent: xvi, 391 p. : ill. ; 25 cm
ISBN: n/a
CID: 37

Phase II trial of cyclophosphamide and cis-platinum for non-small cell bronchogenic carcinoma

Schmidt AM; Blum RH; Clayton M; Speyer JL; Bottino J; Muggia FM
We hypothesized that cyclophosphamide and cis-platinum, without adriamycin, which had been used in previous studies, may be equally efficacious, but less toxic. We treated 27 patients with non-small cell bronchogenic carcinoma with the combination of cyclophosphamide and cis-platinum. We report six responses (25% response rate), with median survival of 79 weeks as compared to 28 weeks in nonresponders (p less than 0.01). Our regimen had acceptable hematologic toxicity and tolerable gastrointestinal toxicity. However, cumulative nephrotoxicity and neurotoxicity were observed. We conclude that cyclophosphamide and cis-platinum may compare favorably to the cyclophosphamide, adriamycin and cis-platinum combination, with respect to response and toxicity
PMID: 6543291
ISSN: 0277-3732
CID: 35105

Phase I-II study of the continuous infusion of doxorubicin in the treatment of non-small cell lung cancer

Green MD; Speyer JS; Bottino JC; Blum RH; Wernz JC; Muggia FM
PMID: 6713422
ISSN: 0361-5960
CID: 15703

Repeated femoral vein cannulation for administration of chemotherapeutic agents

Nidus BD; Speyer JL; Bottino J; Green M; Levin M; Muggia FM
A cannulation set has been designed for repeated short-term infusion of vesicant chemotherapeutic agents via the femoral vein. The major complication was thrombophlebitis in 2.1% of infusions. The procedure provides reliable venous access when therapeutic plans are changed or when the inability to provide catheter care makes an indwelling catheter unwarranted
PMID: 6825128
ISSN: 0361-5960
CID: 28278

ADRIAMYCIN (ADM) 24 HOUR INFUSION - A PHASE-I TRIAL [Meeting Abstract]

SPEYER, JL; BOTTINO, J; NIDUS, B; BLUM, R; WERNZ, JC; LEVIN, M; HYMES, K; MUGGIA, FM
ISI:A1981LH80001428
ISSN: 0197-016x
CID: 40183

Restoring patency of occluded central venous catheters

Hurtubise MR; Bottino JC; Lawson M; McCredie KB
Thrombotic occlusion remains a major cause of central venous catheter removal prior to completion of therapy. Injection of a dilute solution of a potent fibrinolytic agent, urokinase or streptokinase, into the occluded Silastic central venous catheter consistently reestablishes its patency. This procedure was performed on 352 occluded silicone elastomer central venous catheters with only one failure and one minor complication. We recommend this technique for restoring patency of occluded silicone elastomer central venous catheters
PMID: 7356837
ISSN: 0004-0010
CID: 64804

Long-term I.V. therapy: a new approach

Lawson M; Bottino JC; McCredie KB
PMID: 255326
ISSN: 0002-936x
CID: 64805